Maternal and infant immunity against Bordetella pertussis, Norway, 2020 to 2023

Margrethe Greve-Isdahl1,2, Thea Kristine Rogne Møller2, Terese Bekkevold2

  • 1University of Oslo, Oslo, Norway.

Insights

A high number of pregnant women and infants under three months have low pertussis (whooping cough) antibody levels, indicating significant susceptibility. These findings support maternal pertussis vaccination during pregnancy in Norway.

Area of Science:

  • Immunology
  • Public Health
  • Vaccinology

Background:

  • Pertussis (whooping cough) poses a significant health risk to young infants.
  • Norway's current infant vaccination schedule uses an acellular pertussis vaccine (aP) in a hexavalent formulation at 3, 5, and 12 months.

Purpose of the Study:

  • To assess pertussis susceptibility in mothers and infants to inform vaccination strategies.
  • To evaluate the impact of maternal antibodies on infant response to pertussis vaccination.

Main Methods:

  • Prospective observational study of 366 mother/infant pairs (2020-2023).
  • Blood samples collected from mothers (late pregnancy), cord blood, and infants (pre-vaccination and post-vaccination).
  • Multiplex immunoassay used to measure IgG antibody levels against pertussis antigens, diphtheria, and tetanus.

Main Results:

  • 48% of pregnant women had low anti-pertussis toxin (PT) IgG levels (<5 IU/mL).
  • 72% of infants under 3 months had low anti-PT IgG levels before their first vaccine dose.
  • Infants responded well to vaccination; no blunting effect observed from high maternal antibodies.
  • Infants born to mothers boosted within 2 years pre-pregnancy showed low anti-PT IgG levels (58% <5 IU/mL).

Conclusions:

  • A substantial proportion of pregnant women and young infants exhibit low pertussis immunity, suggesting high susceptibility.
  • Findings support the implementation of pertussis vaccination during pregnancy in Norway to protect infants.
  • Maternal vaccination may be crucial for maintaining adequate infant antibody levels against pertussis.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...